Health
Metformin treatment linked to slowed cognitive decline – WebWire
Metformin is the first-line treatment for most cases of type 2 diabetes and one of the most commonly prescribed medications worldwide, with millions of individuals using it to optimise their blood glucose levels. A new research study, conducted over six year…
Metformin is the first-line treatment for most cases of type 2 diabetes and one of the most commonly prescribed medications worldwide, with millions of individuals using it to optimise their blood glucose levels.
A new research study, conducted over six years in the Sydney Memory and Ageing Study in 1037 Australians (aged 70 to 90 years old at baseline), has revealed an additional effect: individuals with type 2 diabetes who used metformin experienced slower cognitive decline with lower dementi…
-
General10 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
General13 hours agoAlbanese beats drum on economy as trade clouds gather
-
Business10 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
Noosa News12 hours agoSurgeon partner of former premier to testify over his patient’s death